05/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

05/2024

May 28, 2024, 14:42 | Blog
David Davis: I am so proud the VCU Health Supply Chain team for the recognition from GHX
Arthur Lodge Kellermann, Health Policy Adviser at Virginia Health Workforce Development Authority, shared a post…
May 28, 2024, 14:38 | Societies
Estela Rodriguez: Keeping up with the press-release literature pre-ASCO24
Estela Rodriguez shared on X: "Keeping up with the press-release literature pre-ASCO24. TROPION-lung01 Datopotamab deruxtecan…
May 28, 2024, 14:34 | Opinion
Join Dr. Carolina Bernabe for a panel session on Preparing for the Transition from Fellowship at ASCO - Florez Lab
Florez Lab shared a post on X: “Featuring Florez Lab members ASCO24! Join Dr. Carolina Bernabe…
May 28, 2024, 14:34 | Drugs
Paolo Tarantino: Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer
Paolo Tarantino shared on X: "Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer.…
May 28, 2024, 14:33 | Societies
Tom Powles: Final results for axitinib/avelumab in 1st line RCC at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X: "Final results for axitinib/avelumab in 1st…
May 28, 2024, 14:25 | Insight
Luis E. Raez: Sometimes new agents don't have a better OS but they provide benefits
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Stephen Liu on…
May 28, 2024, 14:22 | Insight
Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer - UCLA Health
Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to…
May 28, 2024, 14:17 | Insight
Paolo Cortesi discusses the value of axi-cel as a second-line treatment in patients with R/R LBCL - VJHemOnc
VJHemOnc shared on X: "Paolo Cortesi (The University of Milano-Bicocca) discusses the value of axi-cel as a…
May 28, 2024, 14:17 | Societies
ASCO24 Pro Tip by Mandy Davis Aitken
Mandy Davis Aitken, Vice President of Meeting Services at ASCO, shared on X/Twitter: "ASCO24 Pro…
May 28, 2024, 14:17 | Insight
Ramy Sedhom: Updated data from the eSYM trial
Ramy Sedhom shared on X: “Updated data from the eSYM trial - completion of PROs is…
All: 2433 Posts: 271 - 280
Special Coverage